Table 4.
Triterpenoid | Cancer Model | Treatment or Prevention | Combination | Reference |
---|---|---|---|---|
CDDO-Im | Syngeneic L1210 leukemia and B16 melanoma models | Treatment | None | Place et al., 2003 |
CDDO | Xenograft of MDA-MB-435 ER-breast cancer cells | Treatment | None | Lapillonne et al., 2003 |
CDDO-Im | Xenograft of MDA-MB-468 ER-breast cancer cells | Treatment | TRAIL | Hyer et al., 2005 |
CDDO-Im | Liver carcinogenesis induced by aflatoxin in rats | Prevention | None | Yates et al., 2006 |
Liposomal CDDO |
Xenograft of MCF7 ER + breast cancer cells stably overexpressing HER2 | Treatment | None | Konopleva et al., 2006 |
CDDO-Im | Plasmacytomas in iMycEμ transgenic mice | Treatment | None | Han et al., 2006 |
CDDO-Me CDDO-Ea CDDO-Ma |
Lung carcinogenesis induced by vinyl carbamate in A/J mice | Prevention | None | Liby et al., 2007a, 2008a |
Liposomal CDDO-Me |
4T1/BALB/c model of metastatic breast cancer | Treatment | None | Ling et al., 2007 |
Liposomal CDDO CDDO-Im |
TRAF2DN/Bcl-2 transgenic mouse model of CLL and small B-cell lymphoma | Treatment | None | Kress et al., 2007 |
CDDO-Me | Xenograft of Kaposi's sarcoma cells | Treatment | None | Vannini et al., 2007 |
Liposomal CDDO-Me |
APL cells from hMRP8-PML/RARα transgenic mice propagated into syngenic FVB-N mice | Treatment | ATRA | Tabe et al., 2007 |
di-CDDO (TP-225) | Skin carcinogenesis induced by UV radiation in “high-risk” hairless mice | Prevention | None | Dinkova-Kostova et al., 2008 |
CDDO-Me | Xenograft of Dul45 prostate cancer cells in nude rats | Treatment | None | Hyer et al., 2008 |
CDDO-Me | MMTV-neu model of ER- breast cancer | Both | LG100268 | Liby et al., 2008b |
CDDO-Me | Xenograft of PC-3 prostate cancer cells | Treatment | None | Deeb et al., 2009 |
CDDO-Me CDDO-EA |
Lung carcinogenesis induced by vinyl carbamate in A/J mice | Both | LG100268 and NRX194204 | Liby et al., 2009 |
CDDO-Me | Xenograft of MC38 colon cancer cells | Treatment | Tumor-associated antigen vaccine | Nagaraj et al., 2010 |
CDDO-Me | Xenograft of L3.6pL human pancreatic cancer cells | Treatment | None | Jutooru et al., 2010 |
CDDO-Me CDDO-EA |
LSL-KrasG12D/+;LSL-Trp53R127H/+;Pdx-1-Cre mouse model of pancreatic cancer | Prevention | LG100268 | Liby et al., 2010 |
CDDO-Im | Experimental metastasis model –B16F1 melanoma and HT-29 colon cancer cells injected into the mesenteric vein metastasize to the liver | Treatment | None | Townson et al., 2011 |
CDDO | TRAMP model | Prevention | None | Deeb et al., 2011 |
CDDO-Im nanoparticles | Orthotopic injection of primary MMTV-Neu or 4TO7 tumor cells into BALB/c or FVB/NJ mice | Treatment | HER-2 DNA vaccine | Liao et al., 2011 |
CDDO-Me | Brca1Co/Co;MMTV-Cre;p53+/− transgenic mouse model of BRCA1-mutated breast cancer | Prevention | None | Kim et al., 2012 |
CDDO-Me | PyMT model of ER- breast cancer | Prevention | None | Tran et al., 2012 |
MMTV, mouse mammary tumor virus; PyMT, polyoma middle T.